Overview

Clinical Study to Evaluate the Safety and the Efficacy of EscharEx Drug Product (EX-03 Formulation) and Its Placebo Compared to Collagenase, Non-surgical Standard of Care, in Patients With Venous Leg Ulcers

Status:
NOT_YET_RECRUITING

Trial end date:
2028-09-30

Target enrollment:

Participant gender:

Summary

The main objective of this study is: To assess the safety of EscharEx (EX-03 5% formulation) compared to placebo control and compared to Collagenase (NSSOC) in patients with VLU.

Phase:

PHASE2

Details

Lead Sponsor:

MediWound Ltd

Treatments:

Gels